Ginkgo Bioworks Holdings (DNA) Non-Current Assets (2020 - 2026)

Ginkgo Bioworks Holdings posted quarterly Non-Current Assets of $623.1 million for Q1 2026, down 14.52% year-on-year from $728.9 million in Q1 2025, and down 3.82% on a QoQ basis from $647.9 million in Q4 2025.

Ginkgo Bioworks Holdings (DNA) has 7 years of Non-Current Assets data on file, last reported at $623.1 million in Q1 2026.

  • For the quarter ending Q1 2026, Non-Current Assets fell 14.52% year-over-year to $623.1 million; the trailing twelve-month figure through Mar 2026 stood at $2.7 billion (down 15.86% YoY), and the FY2025 full-year result was $647.9 million, down 16.37% from the prior year.
  • Non-Current Assets for Q1 2026 stood at $623.1 million, down from $647.9 million in the prior quarter.
  • Across five years, Non-Current Assets topped out at $1.1 billion in Q1 2023 and bottomed at $351.9 million in Q1 2022.
  • The 5-year median for Non-Current Assets is $708.0 million (2025), against an average of $732.7 million.
  • Peak annual rise in Non-Current Assets reached 213.05% in 2022, while the deepest fall reached 79.6% in 2022.
  • A 5-year view of Non-Current Assets shows it stood at $1.1 billion in 2022, then tumbled by 39.08% to $663.6 million in 2023, then increased by 16.74% to $774.7 million in 2024, then dropped by 16.37% to $647.9 million in 2025, then dropped by 3.82% to $623.1 million in 2026.
  • The last three Non-Current Assets figures came in at $623.1 million (Q1 2026), $647.9 million (Q4 2025), and $683.1 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Assets (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn - 4.56 Mn
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn - 62,953.78
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn 486.60 Mn
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn - 5.83 Mn
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn - 30.30 Mn
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn 14.75 Bn
7 Evaxion A 62.56 Bn 62.54 Bn - -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn 22.66 Bn
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn 910.24 Mn
10 Ginkgo Bioworks Holdings 542.03 Mn 542.03 Mn 16.38 Mn 623.12 Mn

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 623.12 Mn
Dec 31, 2025 647.86 Mn
Sep 30, 2025 683.08 Mn
Jun 30, 2025 707.98 Mn
Mar 31, 2025 728.93 Mn
Dec 31, 2024 774.71 Mn
Sep 30, 2024 818.40 Mn
Jun 30, 2024 841.89 Mn
Mar 31, 2024 678.74 Mn
Dec 31, 2023 663.59 Mn
Sep 30, 2023 884.55 Mn
Jun 30, 2023 1.07 Bn
Mar 31, 2023 1.09 Bn
Dec 31, 2022 1.09 Bn
Sep 30, 2022 408.69 Mn
Jun 30, 2022 395.37 Mn
Mar 31, 2022 351.89 Mn
Dec 31, 2021 347.95 Mn
Sep 30, 2021 340.02 Mn
Jun 30, 2021 1.73 Bn
Mar 31, 2021 1.73 Bn
Dec 31, 2020 248.61 Mn